CranioSense Named Value Finalist at MedTech Innovator 2024

November 2024

We are excited to announce that CranioSense has been selected as a Value Award Finalist by MedTech Innovator (MTI), the world’s largest accelerator for medical device, diagnostic, and digital-health companies. Participation in MTI has provided CranioSense with access to strategic industry mentorship, investor visibility, and potential collaborations with leading healthcare partners.

As part of the program, our team pitched CranioSense’s non-invasive intracranial pressure (ICP) diagnostic platform to top-tier medtech decision-makers — a key milestone in advancing our vision for safer, real-time brain-health monitoring.

🎥 Watch our overview video here: “CranioSense – Overview.”

Our selection as a Value Finalist underscores the strength and promise of our technology as we continue toward clinical development and broader adoption.

Explore the science behind our work on the Technology page, meet our leadership team at Team, or contact us at Contact.